Inflammatory mediator production pathway

The inflammatory mediator production pathway is a complex network of biochemical processes responsible for the synthesis and secretion of signaling molecules that initiate and amplify the inflammatory response. These mediators include cytokines (such as TNF-α, IL-1, and IL-6), chemokines, and lipid-derived molecules like prostaglandins and leukotrienes. The pathway is typically triggered by pattern recognition receptors (PRRs) or cytokine receptors, leading to the activation of intracellular signaling cascades involving kinases like IKK and MAPKs, and transcription factors like NF-κB. Dysregulation of this pathway is a hallmark of numerous chronic inflammatory and autoimmune diseases, including rheumatoid arthritis, inflammatory bowel disease, and asthma. Pharmacological intervention often targets specific nodes within this pathway, such as enzymes (COX-2), receptors (TNFR), or signaling proteins (JAKs), to reduce the production of harmful mediators and alleviate disease symptoms.

Other names

Cytokine production pathwayInflammatory response pathwayPro-inflammatory mediator synthesisInflammatory signaling cascade

Inhibition of key enzymes (e.g., COX, LOX), transcription factors (e.g., NF-κB), or signaling kinases (e.g., JAK, MAPK) that drive the synthesis and release of pro-inflammatory cytokines and lipid mediators.